Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Increased expression of proteins from the G1/S transition of the cell cycle are important in progression in mammary phyllodes tumours — Rooshdiya Z. Karim (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Increased expression of proteins from the G1/S transition of the cell cycle are important in progression in mammary phyllodes tumours
Shared by
Richard A Scolyer
Increased expression of proteins from the G1/S transition of the cell cycle are important in progression in mammary phyllodes tumours
Article
2009
en
Authors
+4 more
RK
Rooshdiya Z. Karim
SG
Sebastien K. Gerega
YY
Yi Yang
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours
Rooshdiya Z. Karim
,
Sebastien K. Gerega
,
Jean Yang
,
Lisa G. Horvath
,
Andrew J. Spillane
,
Hugh Carmalt
,
Richard A Scolyer
,
C S Lee
Article
2009
Proteins from the wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours
Rooshdiya Z. Karim
,
Sebastien K. Gerega
,
Y.H. Yang
,
Lisa Kristina Horvath
,
Andrew J. Spillane
,
Hugh Carmalt
,
Richard A Scolyer
,
C.S. Lee
Article
2009
Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours
Rooshdiya Z. Karim
,
Richard A Scolyer
,
Gary M. Tse
,
Puay‐Hoon Tan
,
Thomas Choudary Putti
,
C. Soon Lee
Article
2005
Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours
Gary M. Tse
,
Alex K.H. Tsang
,
Thomas C. Putti
,
Richard A Scolyer
,
P C W Lui
,
Bonita K.B. Law
,
Rooshdiya Z. Karim
,
C.S. Lee
Article
2010
9. EGFR over expression, not amplification, is involved in the pathogenesis and progression of mammary phyllodes tumours
Rooshdiya Z. Karim
,
Sebastien K. Gerega
,
Yao Yang
,
Gary M. Tse
,
Adrienne Morey
,
Andrew J. Spillane
,
Hugh Carmalt
,
Richard A Scolyer
,
C.S. Lee
Discussion(0)
No comments yet. Be the first to comment.